Cay M Kielty Selected Research

Fibrillins

10/2016	ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions.
1/2014	Epithelial-mesenchymal status influences how cells deposit fibrillin microfibrils.
10/2006	Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain.
8/2006	Elastic fibres in health and disease.
9/2003	Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins.
3/2002	Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury.
2/2002	Fibrillin: from microfibril assembly to biomechanical function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cay M Kielty Research Topics

Disease

6	Marfan Syndrome (Marfan's Syndrome) 08/2013 - 02/2002
4	Weill-Marchesani Syndrome 11/2018 - 01/2012
3	Hyperplasia 04/2014 - 01/2006
3	Cutis Laxa 05/2010 - 08/2006
2	Inflammation (Inflammations) 01/2020 - 01/2017
2	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 08/2013 - 08/2006
2	recessive Cutis laxa 08/2013 - 05/2010
2	Macular Degeneration (Age-Related Maculopathy) 05/2010 - 09/2009
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Necrosis 01/2017
1	Fibrosis (Cirrhosis) 09/2016
1	Neoplasms (Cancer) 09/2016
1	Systemic Scleroderma (Systemic Sclerosis) 06/2015
1	Herpes Zoster 01/2014
1	Autosomal Dominant Cutis Laxa 08/2013
1	Pathologic Neovascularization 01/2010
1	Blindness (Hysterical Blindness) 09/2009
1	Dehydration (Water Stress) 01/2009
1	Vascular Diseases (Vascular Disease) 08/2007
1	Connective Tissue Diseases (Connective Tissue Disease) 08/2006
1	Hypertension (High Blood Pressure) 01/2005
1	Atherosclerosis 01/2005
1	Melanoma (Melanoma, Malignant) 09/2003
1	Dentinogenesis Imperfecta 10/2002
1	Cicatrix (Scar) 03/2002
1	Neointima 03/2002

Drug/Important Bio-Agent (IBA)

7	FibrillinsIBA 10/2016 - 02/2002
6	Fibrillin-1IBA 11/2018 - 09/2003
3	ElastinIBA 08/2013 - 08/2006
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2007 - 03/2002
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2014 - 01/2012
2	arginyl-glycyl-aspartic acidIBA 01/2012 - 09/2003
2	fibulinIBA 05/2010 - 09/2009
2	Biological ProductsIBA 08/2007 - 02/2002
2	Proteins (Proteins, Gene)FDA Link 09/2003 - 10/2002
1	Proteoglycans (Proteoglycan)IBA 01/2020
1	InterferonsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 09/2016
1	Syndecan-2IBA 06/2015
1	Biocompatible Materials (Biomaterials)IBA 04/2014
1	perlecanIBA 01/2014
1	Protein Kinase CIBA 01/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	CateninsIBA 01/2014
1	Cadherins (E-Cadherin)IBA 01/2014
1	Syndecan-4IBA 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Heparin (Liquaemin)FDA LinkGeneric 01/2012
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2010
1	Heavy MetalsIBA 01/2009
1	TropoelastinIBA 10/2006
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 01/2006
1	Tyrosine (L-Tyrosine)FDA Link 10/2002
1	Protein Sorting Signals (Signal Peptide)IBA 10/2002
1	Aspartic Acid (Aspartate)FDA Link 10/2002
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2002

Therapy/Procedure

1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 03/2008